Cancer-type | Pathway | Q-value | P-value | Pathway size | Cancer set size | DP | DN | GP | GN |
parson_gbm | h_vdrPathway:Control of Gene Expression by Vitamin D Receptor | 4.18e-05 | 2.36e-07 | 28 | 116 | 7 | 109 | 28 | 8912 |
parson_gbm | h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation | 4.18e-05 | 4.29e-07 | 31 | 116 | 7 | 109 | 31 | 8909 |
parson_gbm | h_badPathway:Regulation of BAD phosphorylation | 9.42e-05 | 1.45e-06 | 23 | 116 | 6 | 110 | 23 | 8917 |
parson_gbm | h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology | 0.000181 | 3.92e-06 | 45 | 116 | 7 | 109 | 45 | 8895 |
parson_gbm | h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor | 0.000181 | 4.65e-06 | 29 | 116 | 6 | 110 | 29 | 8911 |
parson_gbm | h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes | 0.000527 | 1.68e-05 | 21 | 116 | 5 | 111 | 21 | 8919 |
parson_gbm | h_aktPathway:AKT Signaling Pathway | 0.000527 | 2.04e-05 | 22 | 116 | 5 | 111 | 22 | 8918 |
parson_gbm | h_mapkPathway:MAPKinase Signaling Pathway | 0.000527 | 2.16e-05 | 111 | 116 | 9 | 107 | 111 | 8829 |
parson_gbm | h_mTORPathway:mTOR Signaling Pathway | 0.000636 | 2.94e-05 | 24 | 116 | 5 | 111 | 24 | 8916 |
parson_gbm | h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage | 0.000805 | 4.13e-05 | 12 | 116 | 4 | 112 | 12 | 8928 |
parson_gbm | h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase | 0.00176 | 9.94e-05 | 32 | 116 | 5 | 111 | 32 | 8908 |
parson_gbm | h_egfPathway:EGF Signaling Pathway | 0.00184 | 0.000113 | 33 | 116 | 5 | 111 | 33 | 8907 |
parson_gbm | h_no1Pathway:Actions of Nitric Oxide in the Heart | 0.00194 | 0.000129 | 17 | 116 | 4 | 112 | 17 | 8923 |
parson_gbm | h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway | 0.00428 | 0.000307 | 22 | 116 | 4 | 112 | 22 | 8918 |
parson_gbm | h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity | 0.00464 | 0.000357 | 23 | 116 | 4 | 112 | 23 | 8917 |
parson_gbm | h_g2Pathway:Cell Cycle: G2/M Checkpoint | 0.00473 | 0.000413 | 24 | 116 | 4 | 112 | 24 | 8916 |
parson_gbm | h_rac1Pathway:Rac 1 cell motility signaling pathway | 0.00473 | 0.000413 | 24 | 116 | 4 | 112 | 24 | 8916 |
parson_gbm | h_btg2Pathway:BTG family proteins and cell cycle regulation | 0.00578 | 0.000533 | 10 | 116 | 3 | 113 | 10 | 8930 |
parson_gbm | h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage | 0.00632 | 0.000616 | 27 | 116 | 4 | 112 | 27 | 8913 |
parson_gbm | h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor | 0.00647 | 0.000672 | 11 | 116 | 3 | 113 | 11 | 8929 |
parson_gbm | h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis | 0.00647 | 0.000697 | 28 | 116 | 4 | 112 | 28 | 8912 |
parson_gbm | h_ranbp2Pathway:Sumoylation by RanBP2 Regulates Transcriptional Repression | 0.00706 | 0.000833 | 12 | 116 | 3 | 113 | 12 | 8928 |
parson_gbm | h_cblPathway:CBL mediated ligand-induced downregulation of EGF receptors | 0.00706 | 0.000833 | 12 | 116 | 3 | 113 | 12 | 8928 |
parson_gbm | h_LairPathway:Cells and Molecules involved in local acute inflammatory response | 0.00762 | 0.00102 | 13 | 116 | 3 | 113 | 13 | 8927 |
parson_gbm | h_compPathway:Complement Pathway | 0.00762 | 0.00102 | 13 | 116 | 3 | 113 | 13 | 8927 |
parson_gbm | h_erythPathway:Erythrocyte Differentiation Pathway | 0.00762 | 0.00102 | 13 | 116 | 3 | 113 | 13 | 8927 |
parson_gbm | h_tnfr1Pathway:TNFR1 Signaling Pathway | 0.00792 | 0.00110 | 32 | 116 | 4 | 112 | 32 | 8908 |
parson_gbm | h_hesPathway:Segmentation Clock | 0.00827 | 0.00122 | 14 | 116 | 3 | 113 | 14 | 8926 |
parson_gbm | h_integrinPathway:Integrin Signaling Pathway | 0.00827 | 0.00123 | 58 | 116 | 5 | 111 | 58 | 8882 |
parson_gbm | h_skp2e2fPathway:E2F1 Destruction Pathway | 0.00907 | 0.00145 | 15 | 116 | 3 | 113 | 15 | 8925 |
parson_gbm | h_rasPathway:Ras Signaling Pathway | 0.00907 | 0.00149 | 35 | 116 | 4 | 112 | 35 | 8905 |
parson_gbm | h_tollPathway:Toll-Like Receptor Pathway | 0.00907 | 0.00149 | 35 | 116 | 4 | 112 | 35 | 8905 |
parson_gbm | h_fasPathway:FAS signaling pathway ( CD95 ) | 0.00939 | 0.00164 | 36 | 116 | 4 | 112 | 36 | 8904 |
parson_gbm | h_tffPathway:Trefoil Factors Initiate Mucosal Healing | 0.00939 | 0.00164 | 36 | 116 | 4 | 112 | 36 | 8904 |
parson_gbm | h_crebPathway:Transcription factor CREB and its extracellular signals | 0.01 | 0.00180 | 37 | 116 | 4 | 112 | 37 | 8903 |
parson_gbm | h_agrPathway:Agrin in Postsynaptic Differentiation | 0.0106 | 0.00197 | 38 | 116 | 4 | 112 | 38 | 8902 |
parson_gbm | h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF | 0.0111 | 0.0021 | 66 | 116 | 5 | 111 | 66 | 8874 |
parson_gbm | h_RacCycDPathway:Influence of Ras and Rho proteins on G1 to S Transition | 0.0130 | 0.00254 | 41 | 116 | 4 | 112 | 41 | 8899 |
parson_gbm | h_tidPathway:Chaperones modulate interferon Signaling Pathway | 0.0132 | 0.00264 | 19 | 116 | 3 | 113 | 19 | 8921 |
parson_gbm | h_pmlPathway:Regulation of transcriptional activity by PML | 0.0143 | 0.00301 | 20 | 116 | 3 | 113 | 20 | 8920 |
parson_gbm | h_atrbrcaPathway:Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility | 0.0143 | 0.00301 | 20 | 116 | 3 | 113 | 20 | 8920 |
parson_gbm | h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha) | 0.0144 | 0.00322 | 44 | 116 | 4 | 112 | 44 | 8896 |
parson_gbm | h_ptdinsPathway:Phosphoinositides and their downstream targets. | 0.0144 | 0.00341 | 21 | 116 | 3 | 113 | 21 | 8919 |
parson_gbm | h_cardiacegfPathway:Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy | 0.0144 | 0.00341 | 21 | 116 | 3 | 113 | 21 | 8919 |
parson_gbm | h_mCalpainPathway:mCalpain and friends in Cell motility | 0.0144 | 0.00341 | 21 | 116 | 3 | 113 | 21 | 8919 |
parson_gbm | h_rhoPathway:Rho cell motility signaling pathway | 0.0144 | 0.00341 | 21 | 116 | 3 | 113 | 21 | 8919 |
parson_gbm | h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation | 0.0153 | 0.00374 | 46 | 116 | 4 | 112 | 46 | 8894 |
parson_gbm | h_trkaPathway:Trka Receptor Signaling Pathway | 0.0153 | 0.00384 | 22 | 116 | 3 | 113 | 22 | 8918 |
parson_gbm | h_vegfPathway:VEGF, Hypoxia, and Angiogenesis | 0.0153 | 0.00384 | 22 | 116 | 3 | 113 | 22 | 8918 |
parson_gbm | h_spryPathway:Sprouty regulation of tyrosine kinase signals | 0.0187 | 0.00479 | 24 | 116 | 3 | 113 | 24 | 8916 |
parson_gbm | h_igf1Pathway:IGF-1 Signaling Pathway | 0.022 | 0.00587 | 26 | 116 | 3 | 113 | 26 | 8914 |
parson_gbm | h_telPathway:Telomeres, Telomerase, Cellular Aging, and Immortality | 0.022 | 0.00587 | 26 | 116 | 3 | 113 | 26 | 8914 |
parson_gbm | h_atmPathway:ATM Signaling Pathway | 0.0238 | 0.00646 | 27 | 116 | 3 | 113 | 27 | 8913 |
parson_gbm | h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages | 0.0256 | 0.00709 | 28 | 116 | 3 | 113 | 28 | 8912 |
parson_gbm | h_mta3Pathway:Downregulated of MTA-3 in ER-negative Breast Tumors | 0.035 | 0.00987 | 10 | 116 | 2 | 114 | 10 | 8930 |
parson_gbm | h_keratinocytePathway:Keratinocyte Differentiation | 0.0367 | 0.0105 | 63 | 116 | 4 | 112 | 63 | 8877 |
parson_gbm | h_g1Pathway:Cell Cycle: G1/S Check Point | 0.0368 | 0.0108 | 33 | 116 | 3 | 113 | 33 | 8907 |
parson_gbm | h_pgc1aPathway:Regulation of PGC-1a | 0.0389 | 0.0116 | 11 | 116 | 2 | 114 | 11 | 8929 |
parson_gbm | h_cell2cellPathway:Cell to Cell Adhesion Signaling | 0.0408 | 0.0134 | 12 | 116 | 2 | 114 | 12 | 8928 |
parson_gbm | h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis | 0.0408 | 0.0134 | 12 | 116 | 2 | 114 | 12 | 8928 |
parson_gbm | h_bArrestinPathway:?-arrestins in GPCR Desensitization | 0.0408 | 0.0134 | 12 | 116 | 2 | 114 | 12 | 8928 |
parson_gbm | h_lympathway:Adhesion and Diapedesis of Lymphocytes | 0.0408 | 0.0134 | 12 | 116 | 2 | 114 | 12 | 8928 |
parson_gbm | h_eicosanoidPathway:Eicosanoid Metabolism | 0.0408 | 0.0134 | 12 | 116 | 2 | 114 | 12 | 8928 |
parson_gbm | h_cxcr4Pathway:CXCR4 Signaling Pathway | 0.0408 | 0.0134 | 36 | 116 | 3 | 113 | 36 | 8904 |
parson_gbm | h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae | 0.046 | 0.0153 | 38 | 116 | 3 | 113 | 38 | 8902 |
parson_gbm | h_eponfkbPathway:Erythropoietin mediated neuroprotection through NF-kB | 0.05 | 0.0174 | 14 | 116 | 2 | 114 | 14 | 8926 |
parson_gbm | h_stemPathway:Regulation of hematopoiesis by cytokines | 0.05 | 0.0174 | 14 | 116 | 2 | 114 | 14 | 8926 |
parson_gbm | h_erkPathway:Erk1/Erk2 Mapk Signaling pathway | 0.05 | 0.0174 | 40 | 116 | 3 | 113 | 40 | 8900 |
parson_gbm | h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis | 0.0551 | 0.0195 | 15 | 116 | 2 | 114 | 15 | 8925 |
parson_gbm | h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells | 0.0581 | 0.0209 | 43 | 116 | 3 | 113 | 43 | 8897 |
parson_gbm | h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway | 0.0582 | 0.0218 | 16 | 116 | 2 | 114 | 16 | 8924 |
parson_gbm | h_ps1Pathway:Presenilin action in Notch and Wnt signaling | 0.0582 | 0.0218 | 16 | 116 | 2 | 114 | 16 | 8924 |
parson_gbm | h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors | 0.0582 | 0.0218 | 16 | 116 | 2 | 114 | 16 | 8924 |
parson_gbm | h_alkPathway:ALK in cardiac myocytes | 0.0582 | 0.0221 | 44 | 116 | 3 | 113 | 44 | 8896 |
parson_gbm | h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression | 0.0611 | 0.0241 | 17 | 116 | 2 | 114 | 17 | 8923 |
parson_gbm | h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity | 0.0611 | 0.0241 | 17 | 116 | 2 | 114 | 17 | 8923 |
parson_gbm | h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK) | 0.0611 | 0.0241 | 17 | 116 | 2 | 114 | 17 | 8923 |
parson_gbm | h_tcrPathway:T Cell Receptor Signaling Pathway | 0.0615 | 0.0246 | 46 | 116 | 3 | 113 | 46 | 8894 |
parson_gbm | h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells | 0.064 | 0.0266 | 18 | 116 | 2 | 114 | 18 | 8922 |
parson_gbm | h_p53Pathway:p53 Signaling Pathway | 0.064 | 0.0266 | 18 | 116 | 2 | 114 | 18 | 8922 |
parson_gbm | h_Par1Pathway:Thrombin signaling and protease-activated receptors | 0.064 | 0.0266 | 18 | 116 | 2 | 114 | 18 | 8922 |
parson_gbm | h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart) | 0.0683 | 0.0287 | 49 | 116 | 3 | 113 | 49 | 8891 |
parson_gbm | h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2 | 0.073 | 0.0318 | 20 | 116 | 2 | 114 | 20 | 8920 |
parson_gbm | h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation | 0.073 | 0.0318 | 20 | 116 | 2 | 114 | 20 | 8920 |
parson_gbm | h_CSKPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor | 0.073 | 0.0318 | 20 | 116 | 2 | 114 | 20 | 8920 |
parson_gbm | h_il4Pathway:IL 4 signaling pathway | 0.0774 | 0.0345 | 21 | 116 | 2 | 114 | 21 | 8919 |
parson_gbm | h_il3Pathway:IL 3 signaling pathway | 0.0774 | 0.0345 | 21 | 116 | 2 | 114 | 21 | 8919 |
parson_gbm | h_ctcfPathway:CTCF: First Multivalent Nuclear Factor | 0.0893 | 0.0403 | 23 | 116 | 2 | 114 | 23 | 8917 |
parson_gbm | h_epoPathway:EPO Signaling Pathway | 0.0948 | 0.0433 | 24 | 116 | 2 | 114 | 24 | 8916 |
parson_gbm | h_tnfr2Pathway:TNFR2 Signaling Pathway | 0.100 | 0.0464 | 25 | 116 | 2 | 114 | 25 | 8915 |
parson_gbm | h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system | 0.106 | 0.0495 | 26 | 116 | 2 | 114 | 26 | 8914 |
parson_gbm | h_RELAPathway:Acetylation and Deacetylation of RelA in The Nucleus | 0.109 | 0.0528 | 27 | 116 | 2 | 114 | 27 | 8913 |
parson_gbm | h_gleevecpathway:Inhibition of Cellular Proliferation by Gleevec | 0.109 | 0.0528 | 27 | 116 | 2 | 114 | 27 | 8913 |
parson_gbm | h_stressPathway:TNF/Stress Related Signaling | 0.109 | 0.0528 | 27 | 116 | 2 | 114 | 27 | 8913 |
parson_gbm | h_insulinPathway:Insulin Signaling Pathway | 0.112 | 0.0561 | 28 | 116 | 2 | 114 | 28 | 8912 |
parson_gbm | h_pdgfPathway:PDGF Signaling Pathway | 0.112 | 0.0561 | 28 | 116 | 2 | 114 | 28 | 8912 |
parson_gbm | h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia | 0.112 | 0.0561 | 28 | 116 | 2 | 114 | 28 | 8912 |
parson_gbm | h_edg1Pathway:Phospholipids as signalling intermediaries | 0.112 | 0.0561 | 28 | 116 | 2 | 114 | 28 | 8912 |
parson_gbm | h_il2Pathway:IL 2 signaling pathway | 0.114 | 0.0594 | 29 | 116 | 2 | 114 | 29 | 8911 |
parson_gbm | h_nfkbPathway:NF-kB Signaling Pathway | 0.114 | 0.0594 | 29 | 116 | 2 | 114 | 29 | 8911 |
parson_gbm | h_caspasePathway:Caspase Cascade in Apoptosis | 0.114 | 0.0594 | 29 | 116 | 2 | 114 | 29 | 8911 |
parson_gbm | h_il1rPathway:Signal transduction through IL1R | 0.114 | 0.0594 | 29 | 116 | 2 | 114 | 29 | 8911 |
parson_gbm | h_ghPathway:Growth Hormone Signaling Pathway | 0.125 | 0.0664 | 31 | 116 | 2 | 114 | 31 | 8909 |
parson_gbm | h_gpcrPathway:Signaling Pathway from G-Protein Families | 0.125 | 0.0664 | 31 | 116 | 2 | 114 | 31 | 8909 |
parson_gbm | h_bcrPathway:BCR Signaling Pathway | 0.165 | 0.0887 | 37 | 116 | 2 | 114 | 37 | 8903 |
parson_gbm | h_At1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling | 0.193 | 0.105 | 41 | 116 | 2 | 114 | 41 | 8899 |
parson_gbm | h_ranMSpathway:Role of Ran in mitotic spindle regulation | 0.218 | 0.121 | 9 | 116 | 1 | 115 | 9 | 8931 |
parson_gbm | h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy | 0.218 | 0.121 | 9 | 116 | 1 | 115 | 9 | 8931 |
parson_gbm | h_pyk2Pathway:Links between Pyk2 and Map Kinases | 0.225 | 0.126 | 46 | 116 | 2 | 114 | 46 | 8894 |
parson_gbm | h_mef2dPathway:Role of MEF2D in T-cell Apoptosis | 0.232 | 0.132 | 10 | 116 | 1 | 115 | 10 | 8930 |
parson_gbm | h_glycolysisPathway:Glycolysis Pathway | 0.232 | 0.132 | 10 | 116 | 1 | 115 | 10 | 8930 |
parson_gbm | h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway | 0.241 | 0.143 | 11 | 116 | 1 | 115 | 11 | 8929 |
parson_gbm | h_monocytePathway:Monocyte and its Surface Molecules | 0.241 | 0.143 | 11 | 116 | 1 | 115 | 11 | 8929 |
parson_gbm | h_prionPathway:Prion Pathway | 0.241 | 0.143 | 11 | 116 | 1 | 115 | 11 | 8929 |
parson_gbm | h_GATA3pathway:GATA3 participate in activating the Th2 cytokine genes expression | 0.241 | 0.143 | 11 | 116 | 1 | 115 | 11 | 8929 |
parson_gbm | h_eradPathway:ER?associated degradation (ERAD) Pathway | 0.241 | 0.143 | 11 | 116 | 1 | 115 | 11 | 8929 |
parson_gbm | h_metPathway:Signaling of Hepatocyte Growth Factor Receptor | 0.253 | 0.152 | 52 | 116 | 2 | 114 | 52 | 8888 |
parson_gbm | h_akapCentrosomePathway:Protein Kinase A at the Centrosome | 0.253 | 0.154 | 12 | 116 | 1 | 115 | 12 | 8928 |
parson_gbm | h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development | 0.253 | 0.154 | 12 | 116 | 1 | 115 | 12 | 8928 |
parson_gbm | h_HBxPathway:Calcium Signaling by HBx of Hepatitis B virus | 0.26 | 0.165 | 13 | 116 | 1 | 115 | 13 | 8927 |
parson_gbm | h_prc2Pathway:The PRC2 Complex Sets Long-term Gene Silencing Through Modification of Histone Tails | 0.26 | 0.165 | 13 | 116 | 1 | 115 | 13 | 8927 |
parson_gbm | h_ranklPathway:Bone Remodelling | 0.26 | 0.165 | 13 | 116 | 1 | 115 | 13 | 8927 |
parson_gbm | h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase | 0.26 | 0.165 | 13 | 116 | 1 | 115 | 13 | 8927 |
parson_gbm | h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway | 0.26 | 0.165 | 55 | 116 | 2 | 114 | 55 | 8885 |
parson_gbm | h_ucalpainPathway:uCalpain and friends in Cell spread | 0.268 | 0.176 | 14 | 116 | 1 | 115 | 14 | 8926 |
parson_gbm | h_d4gdiPathway:D4-GDI Signaling Pathway | 0.268 | 0.176 | 14 | 116 | 1 | 115 | 14 | 8926 |
parson_gbm | h_fibrinolysisPathway:Fibrinolysis Pathway | 0.268 | 0.176 | 14 | 116 | 1 | 115 | 14 | 8926 |
parson_gbm | h_vipPathway:Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells | 0.268 | 0.176 | 14 | 116 | 1 | 115 | 14 | 8926 |
parson_gbm | h_arapPathway:ADP-Ribosylation Factor | 0.28 | 0.187 | 15 | 116 | 1 | 115 | 15 | 8925 |
parson_gbm | h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis | 0.28 | 0.187 | 15 | 116 | 1 | 115 | 15 | 8925 |
parson_gbm | h_smPathway:Spliceosomal Assembly | 0.285 | 0.197 | 16 | 116 | 1 | 115 | 16 | 8924 |
parson_gbm | h_amiPathway:Acute Myocardial Infarction | 0.285 | 0.197 | 16 | 116 | 1 | 115 | 16 | 8924 |
parson_gbm | h_longevityPathway:The IGF-1 Receptor and Longevity | 0.285 | 0.197 | 16 | 116 | 1 | 115 | 16 | 8924 |
parson_gbm | h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System | 0.285 | 0.197 | 16 | 116 | 1 | 115 | 16 | 8924 |
parson_gbm | h_il17Pathway:IL 17 Signaling Pathway | 0.285 | 0.197 | 16 | 116 | 1 | 115 | 16 | 8924 |
parson_gbm | h_cd40Pathway:CD40L Signaling Pathway | 0.293 | 0.207 | 17 | 116 | 1 | 115 | 17 | 8923 |
parson_gbm | h_PDZsPathway:Synaptic Proteins at the Synaptic Junction | 0.293 | 0.207 | 17 | 116 | 1 | 115 | 17 | 8923 |
parson_gbm | h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2 | 0.293 | 0.207 | 17 | 116 | 1 | 115 | 17 | 8923 |
parson_gbm | h_il7Pathway:IL-7 Signal Transduction | 0.297 | 0.217 | 18 | 116 | 1 | 115 | 18 | 8922 |
parson_gbm | h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways | 0.297 | 0.217 | 18 | 116 | 1 | 115 | 18 | 8922 |
parson_gbm | h_tall1Pathway:TACI and BCMA stimulation of B cell immune responses. | 0.297 | 0.217 | 18 | 116 | 1 | 115 | 18 | 8922 |
parson_gbm | h_41bbPathway:The 4-1BB-dependent immune response | 0.297 | 0.217 | 18 | 116 | 1 | 115 | 18 | 8922 |
parson_gbm | h_cytokinePathway:Cytokine Network | 0.297 | 0.217 | 18 | 116 | 1 | 115 | 18 | 8922 |
parson_gbm | h_barr-mapkPathway:Role of ?-arrestins in the activation and targeting of MAP kinases | 0.308 | 0.227 | 19 | 116 | 1 | 115 | 19 | 8921 |
parson_gbm | h_etsPathway:METS affect on Macrophage Differentiation | 0.319 | 0.237 | 20 | 116 | 1 | 115 | 20 | 8920 |
parson_gbm | h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway | 0.338 | 0.257 | 22 | 116 | 1 | 115 | 22 | 8918 |
parson_gbm | h_ngfPathway:Nerve growth factor pathway (NGF) | 0.338 | 0.257 | 22 | 116 | 1 | 115 | 22 | 8918 |
parson_gbm | h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development | 0.338 | 0.257 | 22 | 116 | 1 | 115 | 22 | 8918 |
parson_gbm | h_cdMacPathway:Cadmium induces DNA synthesis and proliferation in macrophages | 0.349 | 0.266 | 23 | 116 | 1 | 115 | 23 | 8917 |
parson_gbm | h_mPRPathway:How Progesterone Initiates the Oocyte Maturation | 0.356 | 0.276 | 24 | 116 | 1 | 115 | 24 | 8916 |
parson_gbm | h_inflamPathway:Cytokines and Inflammatory Response | 0.356 | 0.276 | 24 | 116 | 1 | 115 | 24 | 8916 |
parson_gbm | h_cellcyclePathway:Cyclins and Cell Cycle Regulation | 0.366 | 0.285 | 25 | 116 | 1 | 115 | 25 | 8915 |
parson_gbm | h_TPOPathway:TPO Signaling Pathway | 0.375 | 0.294 | 26 | 116 | 1 | 115 | 26 | 8914 |
parson_gbm | h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling | 0.382 | 0.303 | 27 | 116 | 1 | 115 | 27 | 8913 |
parson_gbm | h_il6Pathway:IL 6 signaling pathway | 0.382 | 0.303 | 27 | 116 | 1 | 115 | 27 | 8913 |
parson_gbm | h_ceramidePathway:Ceramide Signaling Pathway | 0.401 | 0.321 | 29 | 116 | 1 | 115 | 29 | 8911 |
parson_gbm | h_bArrestin-srcPathway:Roles of ?-arrestin-dependent Recruitment of Src Kinases in GPCR Signaling | 0.41 | 0.33 | 30 | 116 | 1 | 115 | 30 | 8910 |
parson_gbm | h_tgfbPathway:TGF beta signaling pathway | 0.449 | 0.364 | 34 | 116 | 1 | 115 | 34 | 8906 |
parson_gbm | h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors | 0.453 | 0.372 | 35 | 116 | 1 | 115 | 35 | 8905 |
parson_gbm | h_fMLPpathway:fMLP induced chemokine gene expression in HMC-1 cells | 0.453 | 0.372 | 35 | 116 | 1 | 115 | 35 | 8905 |
parson_gbm | h_malPathway:Role of MAL in Rho-Mediated Activation of SRF | 0.46 | 0.38 | 36 | 116 | 1 | 115 | 36 | 8904 |
parson_gbm | h_p38mapkPathway:p38 MAPK Signaling Pathway | 0.513 | 0.426 | 42 | 116 | 1 | 115 | 42 | 8898 |
parson_gbm | h_erk5Pathway:Role of Erk5 in Neuronal Survival | 1 | 1 | 26 | 116 | 0 | 116 | 26 | 8914 |
parson_gbm | h_Ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage | 1 | 1 | 12 | 116 | 0 | 116 | 12 | 8928 |
parson_gbm | h_thelperPathway:T Helper Cell Surface Molecules | 1 | 1 | 12 | 116 | 0 | 116 | 12 | 8928 |
parson_gbm | h_setPathway:Granzyme A mediated Apoptosis Pathway | 1 | 1 | 12 | 116 | 0 | 116 | 12 | 8928 |
parson_gbm | h_hsp27Pathway:Stress Induction of HSP Regulation | 1 | 1 | 13 | 116 | 0 | 116 | 13 | 8927 |
parson_gbm | h_rabPathway:Rab GTPases Mark Targets In The Endocytotic Machinery | 1 | 1 | 14 | 116 | 0 | 116 | 14 | 8926 |
parson_gbm | h_eif2Pathway:Regulation of eIF2 | 1 | 1 | 11 | 116 | 0 | 116 | 11 | 8929 |
parson_gbm | h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules | 1 | 1 | 14 | 116 | 0 | 116 | 14 | 8926 |
parson_gbm | h_wntPathway:WNT Signaling Pathway | 1 | 1 | 27 | 116 | 0 | 116 | 27 | 8913 |
parson_gbm | h_reckPathway:Inhibition of Matrix Metalloproteinases | 1 | 1 | 14 | 116 | 0 | 116 | 14 | 8926 |
parson_gbm | h_calcineurinPathway:Effects of calcineurin in Keratinocyte Differentiation | 1 | 1 | 11 | 116 | 0 | 116 | 11 | 8929 |
parson_gbm | h_bcellsurvivalPathway:B Cell Survival Pathway | 1 | 1 | 13 | 116 | 0 | 116 | 13 | 8927 |
parson_gbm | h_sppaPathway:Aspirin Blocks Signaling Pathway Involved in Platelet Activation | 1 | 1 | 27 | 116 | 0 | 116 | 27 | 8913 |
parson_gbm | h_tcapoptosisPathway:HIV Induced T Cell Apoptosis | 1 | 1 | 10 | 116 | 0 | 116 | 10 | 8930 |
parson_gbm | h_actinYPathway:Y branching of actin filaments | 1 | 1 | 11 | 116 | 0 | 116 | 11 | 8929 |
parson_gbm | h_ctlPathway:CTL mediated immune response against target cells | 1 | 1 | 14 | 116 | 0 | 116 | 14 | 8926 |
parson_gbm | h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells | 1 | 1 | 11 | 116 | 0 | 116 | 11 | 8929 |
parson_gbm | h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents | 1 | 1 | 12 | 116 | 0 | 116 | 12 | 8928 |
parson_gbm | h_akap95Pathway:AKAP95 role in mitosis and chromosome dynamics | 1 | 1 | 9 | 116 | 0 | 116 | 9 | 8931 |
parson_gbm | h_shhPathway:Sonic Hedgehog (Shh) Pathway | 1 | 1 | 10 | 116 | 0 | 116 | 10 | 8930 |
parson_gbm | h_CCR3Pathway:CCR3 signaling in Eosinophils | 1 | 1 | 31 | 116 | 0 | 116 | 31 | 8909 |
parson_gbm | h_tob1Pathway:Role of Tob in T-cell activation | 1 | 1 | 15 | 116 | 0 | 116 | 15 | 8925 |
parson_gbm | h_granulocytesPathway:Adhesion and Diapedesis of Granulocytes | 1 | 1 | 13 | 116 | 0 | 116 | 13 | 8927 |
parson_gbm | h_nktPathway:Selective expression of chemokine receptors during T-cell polarization | 1 | 1 | 27 | 116 | 0 | 116 | 27 | 8913 |
parson_gbm | h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation | 1 | 1 | 13 | 116 | 0 | 116 | 13 | 8927 |
parson_gbm | h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development | 1 | 1 | 21 | 116 | 0 | 116 | 21 | 8919 |
parson_gbm | h_gcrPathway:Corticosteroids and cardioprotection | 1 | 1 | 14 | 116 | 0 | 116 | 14 | 8926 |
parson_gbm | h_bbcellPathway:Bystander B Cell Activation | 1 | 1 | 9 | 116 | 0 | 116 | 9 | 8931 |
parson_gbm | h_blymphocytePathway:B Lymphocyte Cell Surface Molecules | 1 | 1 | 11 | 116 | 0 | 116 | 11 | 8929 |
parson_gbm | h_asbcellPathway:Antigen Dependent B Cell Activation | 1 | 1 | 13 | 116 | 0 | 116 | 13 | 8927 |
parson_gbm | h_mhcPathway:Antigen Processing and Presentation | 1 | 1 | 7 | 116 | 0 | 116 | 7 | 8933 |
parson_gbm | h_th1th2Pathway:Th1/Th2 Differentiation | 1 | 1 | 21 | 116 | 0 | 116 | 21 | 8919 |
parson_gbm | h_il5Pathway:IL 5 Signaling Pathway | 1 | 1 | 11 | 116 | 0 | 116 | 11 | 8929 |